(7) D E Beck, W B Sweeney, and M D McCarter (2014) Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients International Journal of Colorectal Disease, 2014 Dec, Volume 29 (Issue 12), Pages 1527-34
Bone healing effects: Less researched than BPC-157 for bone specifically
The medication suppresses appetite effectively, but it does not protect muscle
[28] [29] The appetite-suppressing effects of semaglutide may further compromise nutritional intake, necessitating close monitoring of nutritional markers, body composition, and supplementation adherence
Outside of the US, generics manufacturers are poised to pounce as soon as semaglutide patents expire
B., Brasky, K